Laxatives pp 69-80 | Cite as


  • Francesco Capasso
  • Timothy S. Gaginella


Ricinoleic Acid Intestinal Secretion Laxative Abuse Melanosis Coli Intestinal Permeation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. al-Dakan AA, al-Tuffail M, Hannan MA (1995) Cassia senna inhibits mutagenic activities of benzo [α]-pyrene, aflatoxin B1, shamma and methyl methansulfonate. Pharmacol Toxicol 77: 288–292PubMedCrossRefGoogle Scholar
  2. Anderson AS (1986) Dietary factors in the etiology and treatment of constipation during pregnancy. Br J Obstet Gynaecol 93: 245–249PubMedCrossRefGoogle Scholar
  3. Andorsky RI, Major MD, Goldner F (1990) Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 85: 261–265PubMedGoogle Scholar
  4. Autore G, Capasso F, Mascolo N (1984) Phenolphthalein stimulates the formation of histamine, 5-hydroxytryptamine and prostaglandin-like material by rat jejunum, ileum and colon. Br J Pharmacol 81: 347–349PubMedGoogle Scholar
  5. Autore G, Caliendo G, Pepe A, Capasso F (1990a) Perfusion of rat colon with sennosides, rhein and rheinanthrone. Dose related histamine release. Eur J Pharmacol 191: 97–99PubMedCrossRefGoogle Scholar
  6. Autore G, Calignano A, Mascolo N, Capasso F (1990b) Role of kinins in the laxation induced by castor oil. Pharmacol Life Sci Adv 9: 51–54Google Scholar
  7. Badiali D, Marcheggiano A, Pallone S, Paoluzi T, Rausano G, Jannoni C, Materia E, Anzini S, Corazziari E (1985) Melanosis of the rectum in patients with chronic constipation. Dis Colon Rectum 28: 241–245PubMedCrossRefGoogle Scholar
  8. Balaa MA, Powell DW (1986) Prostaglandin synthesis by enterocyte microsomes of rabbit small intestine. Prostaglandins 31: 609–624PubMedCrossRefGoogle Scholar
  9. Balasz M (1986) Melanosis coli. Ultrastructural study of 45 patients. Dis Colon Rectum 29: 839–844CrossRefGoogle Scholar
  10. Baldwin WF (1963) Clinical study of senna administration to nursing mothers. Assessment of effects on infants bowel habits. Can Med Assoc J 89: 566–568PubMedGoogle Scholar
  11. Bardon T, Deragnauncourt J (1985) Effects of platelet activating factor (PAF) on the digestive mobility in the conscious rat. Dig Dis Sci 30: 738–765Google Scholar
  12. Bauer H (1977) Behandlung der Obstipation mit Laxantien in der gynakologischen Praxis. Ther Gegenwart 116: 2305–2312PubMedGoogle Scholar
  13. Beck H, Beck K (1982) Schaufenster (Suppl Deutsche Apotheker Zeitung) 31: 33–34Google Scholar
  14. Becker GL (1952) The case against mineral oil. Am J Dig Dis 19: 344–348PubMedCrossRefGoogle Scholar
  15. Bennett A (1992) Control of gastrointestinal motility. In: Capasso F, Mascolo N (eds) Natural drugs and the digestive tract. EMSI, Rome, pp 1–5Google Scholar
  16. Bennett A, Eley KG (1976) Intestinal pH and propulsion: an explanation of diarrhea in lactose deficiency and laxation by lactulose. J Pharm Pharmacol 28: 192–195PubMedCrossRefGoogle Scholar
  17. Bennett PN (1988) Drugs and human lactation. Elsevier, New York, NYGoogle Scholar
  18. Bennett WG, Cerda JJ (1996) Dietary fibers: Fact and fiction. Dig Dis 14: 43–58PubMedCrossRefGoogle Scholar
  19. Benveniste J (1988) PAF-acether, an other phospholipid with biological activity. In: Karnovsky ML, Leaf A, Bolis LC (eds) Biological membranes. Liss, New York, pp 73–85Google Scholar
  20. Berridge M (1983) Phosphatidylinositol hydrolysis: a general transducing mechanism of calcium-mobilizing receptors. In: Turnberg LA (ed) Intestinal secretion. Knapp Drewett and Sons, Great Britain, pp 28–34Google Scholar
  21. Beubler E (1985) Influence of chronic bisacodyl treatment on the effect of acute bisacodyl on water and electrolyte transport in the rat colon. J Pharm Pharmacol 37: 131–133PubMedCrossRefGoogle Scholar
  22. Beubler E, Juan N (1978) PGE-mediated laxative effect of diphenolic laxatives. Naunyn Schmiedeberg’s Arch Pharmacol 305: 241–246CrossRefGoogle Scholar
  23. Beubler E, Juan N (1979) Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon. J Pharm Pharmacol 31: 681–685PubMedCrossRefGoogle Scholar
  24. Beubler E, Kollar G (1985) Stimulation of PGE2 synthesis and water and electrolyte secretion by senna anthraquinones is inhibited by indomethacin. J Pharm Pharmacol 32:248–251CrossRefGoogle Scholar
  25. Binder HJ (1989) Absorption and secretion of water and electrolytes by small and large intestine. In: Sleisenger MH, Fordtran JS (eds) Gastrointestinal disease, 4th ed. Saunders, Philadelphia, pp 1022–1045Google Scholar
  26. Binder HJ (1977) Pharmacology of laxatives. Annu Rev Pharmacol Toxicol 17: 355–367PubMedCrossRefGoogle Scholar
  27. Binder HJ (1988) Use of laxatives in clinical medicine. Pharmacology 36 (Suppl 1): 226–229PubMedCrossRefGoogle Scholar
  28. Boisson J (1990) Essai du Duphalac (lactulose) pour le sevrage de laxatifs irritants. Le Concours Medical 10: 112–132Google Scholar
  29. Bolton J, Field M (1977) Ca ionophore stimulated ion secretion in rabbit ileal mucosa: relations to actions of cyclic 3′, 5′-AMP and carbamylcholine. J Membr Biol 35: 159–163PubMedCrossRefGoogle Scholar
  30. Boyd JT, Doll R (1954) Gastro-intestinal cancer and the use of liquid paraffin. Br J Cancer 8: 231–237PubMedCrossRefGoogle Scholar
  31. Bretagne J, Vidon N, L’Hirondel C, Bernier JJ (1981) Increased cell loss in the human jejunum induced by laxatives (ricinoleic acid, dioctyl sodium sulphosuccinate, magnesium sulphate, bile salts). Gut 22: 264–269PubMedCrossRefGoogle Scholar
  32. Brooks SJH (1993) Neuronal nitric oxide in the gut. J Gastroenterol Hepatol 8: 590–593CrossRefGoogle Scholar
  33. Brown JP, Brown RJ (1976) Mutagenesis by 9,10 anthraquinone derivatives and related compounds in Salmonella thyphimurium. Mutat Res 40: 203–224PubMedCrossRefGoogle Scholar
  34. Brunton LL (1990) Agents affecting gastrointestinal water flux motility, digestants and bile acids. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 914–932Google Scholar
  35. Brusick D, Mengs U (1997) Assessment of the genotoxic risk from laxative senna products. Environ Mol Mutagen 29: 1–9PubMedCrossRefGoogle Scholar
  36. Buckley TL, Hoult JRS (1989) Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors. Eur J Pharmacol 163: 273–283CrossRefGoogle Scholar
  37. Bueno L, Frexinos J, Fioramonti J (1988) Role of motility in pathogenesis of constipation and diarrhea. Pharmacology 36 (Suppl 1): 15–22PubMedCrossRefGoogle Scholar
  38. Burgess DE (1972) Constipation in obstetrics. In: Jones FA, Godding EW (eds) Management of constipation. Blackwell Scientific, Oxford, pp 176–188Google Scholar
  39. Cameron BD, Phillips MWA, Fenerty CA (1988) Milk transfer of rhein in the rhesus monkey. Pharmacology 36 (Suppl 1): 221–225PubMedCrossRefGoogle Scholar
  40. Campbell CM, Detwiller AK (1930) The lazy colon. Newer methods and latest advances of science in the treatment of constipation, 7th edn. The Educational Press, New York, p 312Google Scholar
  41. Campbell-Mackie M (1963) The re-educative treatment of bowel dysfunction in infant and children. S Afr Med J 37: 675–678PubMedGoogle Scholar
  42. Capasso F (1993) Lassativi e purganti. Aboca, Sansepolcro, pp 21 and 104Google Scholar
  43. Capasso F, Tavares IA, Tsang R, Bennett A (1985) The role of calcium on eicosanoid production induced by ricinoleic acid or the calcium ionophore A23187. Prostaglandins 30: 119–124PubMedCrossRefGoogle Scholar
  44. Capasso F, Mascolo N, Autore G, Romano V (1986) Laxatives and the production of autacoids by rat colon. J Pharm Pharmacol 38: 627–629PubMedCrossRefGoogle Scholar
  45. Capasso F, Tavares IA, Bennett A (1992) PAF formation by human gastrointestinal mucosa/submucosa in vitro: release by ricinoleic acid and inhibition by 5-aminosalicylic acid. J Pharm Pharmacol 44: 771–772PubMedCrossRefGoogle Scholar
  46. Capasso F, Izzo AA, Mascolo N, Autore G, Di Carlo G (1993) Effect of senna is not mediated by platelet-activating factor. Pharmacology 47 (Suppl 1): 58–63PubMedCrossRefGoogle Scholar
  47. Capasso F, Di Carlo R (1994) Purganti, lassativi ed antidiarroici. In: Giotti A et al (eds) Farmacologia clinica e chemioterapia, 3a ed, Vol 1. UTET, Torino, pp 1227–1231Google Scholar
  48. Capasso F, Mascolo N, Izzo AA, Gaginella TS (1994) Dissociation of castor oil-induced diarrhea and intestinal mucosal injury in rat: effect of NG-nitro-L-arginine methyl ester Br J Pharmacol 113: 1127–1130PubMedGoogle Scholar
  49. Caren JF, Meyer JH, Grossman MI (1974) Canine intestinal secretion during and after rapid distension of the small bowel. Am J Physiol 227: 183–188PubMedGoogle Scholar
  50. Case RM, Hardcastle J, Hardcastle PT (1983) Calcium and secretory process. In: Turnberg LA (ed) Intestinal Secretion. Knapp Drewett and Sons, Great Britain, pp 24–28Google Scholar
  51. Christensen J (1987) Motility of the colon. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven Press, New York, pp 665–693Google Scholar
  52. Cline WS, Lorenzsonn V, Benz L, Bass P, Olsen WA (1979) The effects of sodium ricinoleate on small intestinal function and structure. J Clin Invest 58: 380–390CrossRefGoogle Scholar
  53. Code CF, Bass P, McClary GB Jr, Newnum RL, Orvin AL (1960) Absorption of water, sodium and potassium in small intestine of dogs. Am J Physiol 199: 281–288PubMedGoogle Scholar
  54. Colombo P (1994) Trattamento della stipsi cronica in soggetti anziani. Arch Med Interna 46: 1–17Google Scholar
  55. Corbett CL, Issacs PET, Riley AK, Turnberg LA (1977) Human intestinal transport in vitro. Gut 18: 136–140PubMedCrossRefGoogle Scholar
  56. Cummings JH (1974) Progress report: Laxative abuse. Gut 15: 758–766PubMedCrossRefGoogle Scholar
  57. Cummings JW (1978) Dietary fibre and colonic function. J R Soc Med 71: 81–86PubMedGoogle Scholar
  58. Dawson JR, Schwenk M (1989) Isolated epithelial cells. Progress in Pharmacol Clin Pharmacol 7: 21–41Google Scholar
  59. De Jonge HR (1975) The response of small intestine villous and crypt epithelium to cholera-toxin in rat and guinea-pig. Evidence against a specific role of the crypt cells in choleragen-induced secretion. Biochim Biophys Acta 381: 128PubMedCrossRefGoogle Scholar
  60. de Witte P, Dreessen M, Lemli J (1991) The influence of some anthracene and diphenylmethane derivatives on water and electrolyte movement in rat colon. Pharm Acta Helv 66: 70–73PubMedGoogle Scholar
  61. De Wolf FA, Edelbrock PM, de Haas EJM, Vermeij P (1983) Experience with a screening method for laxative abuse. Hum Toxicol 2: 385–389CrossRefGoogle Scholar
  62. Di Palma JA, Brady CE (1989) Colon cleansing for diagnostic and surgical procedures: Polyethylene glycol-electrolyte lavage solution. Am J Gastroenterol 84: 1008–1016Google Scholar
  63. Dobb GJ, Edis RH (1984) Coma and neuropathy after ingestion of herbal laxative containing podophyllin. Med J Aust 140: 495–496PubMedGoogle Scholar
  64. Dolman D, Edmonds CJ (1975) The effect of aldosterone and the renin angiotensin system on sodium, potassium and chloride transport by proximal and distal rat colon in vivo. J Physiol (Lond) 250: 597–611Google Scholar
  65. Donowitz M, Welsh MJ (1987) Regulation of mammalian small intestinal electrolyte secretion. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven Press, New York, pp 1351–1388Google Scholar
  66. Douthwaith A, Goulding R (1957) Action of senna. Br Med J 4: 1414–1415CrossRefGoogle Scholar
  67. Dreessen M, Lemli J (1988) Studies in the field of drugs containing anthraquinone derivatives. The metabolism of cascarosides by intestinal bacteria. Pharm Acta Helv 63: 287–289PubMedGoogle Scholar
  68. Dubecq JP, Palmade JL (1974) Etude de l’administration de Tamarine chez la mère qui allaite. Gaz Med Fr 81: 5173–5175Google Scholar
  69. Dufour P, Gendre P (1984) Ultrastructure of mouse intestinal mucosa and changes observed after long-term anthraquinone administration. Gut 15: 1358–1363CrossRefGoogle Scholar
  70. Dufour P, Gendre P (1988) Long-term mucosal alterations by sennosides and related compounds. Pharmacology 36 (Suppl 1): 194–202PubMedCrossRefGoogle Scholar
  71. Duncan AS (1957) Standardized senna as a laxative in the puerperium. A clinical assessment. Br Med J 1:439–441PubMedCrossRefGoogle Scholar
  72. Ewe K (1987) Effect of bisacodyl on intestinal electrolyte and water net transport and transit. Digestion 37: 247–253PubMedCrossRefGoogle Scholar
  73. Faber P, Strenge-Hesse A (1988) Relevance of rhein excretion into breast milk. Pharmacology 36 (Suppl 1): 212–220PubMedCrossRefGoogle Scholar
  74. Farack U, Nell G (1984) Mechanism of action of diphenolic laxatives: The role of adenylate cyclase and mucosal permeability. Digestion 30: 191–194PubMedCrossRefGoogle Scholar
  75. Farack U, Gruber E, Loeschke K (1985) The influence of bisacodyl on mucus secretion, mucus synthesis and electrolyte movements in the rat colon in vivo. Eur J Pharmacol 117: 215–222PubMedCrossRefGoogle Scholar
  76. Ferlemann G, Vogt W (1965) Entazetylierung und Resorption von phenolischen Laxantien. Arch Exp Path Pharmak 250: 479–487CrossRefGoogle Scholar
  77. Field M, Smith PL, Bolton JE (1980) Ion transport across the isolated small intestinal mucosa of the winter flounder Pseudopleuronectes american: II Effects of cyclic AMP. J Membr Biol 55: 157PubMedCrossRefGoogle Scholar
  78. Fingl E (1975) Laxatives and cathartics. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 976–986Google Scholar
  79. Fireman Z, Rozen P, Fine N, et al. (1989) Reproducibility studies and effects of bowel preparation on measurements of rectal epithelial proliferations. Cancer Lett 45: 59–64PubMedCrossRefGoogle Scholar
  80. Fleischer N, Brown H, Graham DY, Delena S (1969) Chronic laxative-induced hyperaldosteronism and hypokalemia stimulating Bartter’s syndrome. Ann Intern Med 70: 791–798PubMedGoogle Scholar
  81. Fleming BJ, Genuth SM, Gould AB, Kaminonkowski MD (1975) Effects of potassium and sodium replacement on the renin-angiotensin-aldosterone system. Ann Int Med 83: 60–62PubMedGoogle Scholar
  82. Forman DT, Garvin JE, Forestner JE, Taylor CB (1968) Increased excretion of fecal bile acids by an oral hydrophilic colloid. Proc Soc Exp Biol Med 127: 1060–1063PubMedGoogle Scholar
  83. Forth W, Rummel W, Baldauf J (1966) Wasser — und Elektrolytbewegung am Dünn — und Dickdarm unter dem Einfluss von Laxantien, ein Beitrag zur Klärung ihres Wirkungsmechanismus. Arch Pharmak Exp Path 254: 18–32Google Scholar
  84. Freiman DG, Engelberg H, Merrit WH (1940) Oil aspiration pneumonia in adults: a study of 47 patients. Arch Intern Med 66: 11–38CrossRefGoogle Scholar
  85. Frexinos J, Staumont G, Fioramonti J, Bueno L (1989) Effects of sennosides on colonic myoelectrical activity in man. Dig Dis Sci 34: 214–219PubMedCrossRefGoogle Scholar
  86. Gaginella TS (1977) The management of gastrointestinal disorders. II. Use and misuse of laxatives. J Continuing Education of Pharmacy 1: 19–28Google Scholar
  87. Gaginella TS (1990a) Eicosanoid-mediated intestinal secretion. In: Lebenthal E, Duffey M (eds) Secretory diarrhea. Raven Press, New York, pp 15–30Google Scholar
  88. Gaginella TS (1990b) Receptor pharmacology of intestinal secretion. In: Lebenthal E, Duffey M (eds) Secretory diarrhea. Raven Press, New York, pp 163–178Google Scholar
  89. Gaginella TS (1995a) Laxative drugs. In: Munson PL, Mueller RA and Breese GR (eds) Principles of Pharmacology. Chapman and Hall, New YorkGoogle Scholar
  90. Gaginella TS (ed) (1995b) Handbook of methods in gastrointestinal pharmacology. CRC Press, Boca RatonGoogle Scholar
  91. Gaginella TS, Bass P (1978) Laxatives: An uptade on mechanism of action. Life Sci 23: 1001–1010Google Scholar
  92. Gaginella TS, Phillips SF (1975) Ricinoleic acid: current view of an ancient oil. Am J Dig Dis 20: 1171–1177PubMedCrossRefGoogle Scholar
  93. Gaginella TS, Hubel KA, O’Dorisio TM (1982) Vasoactive intestinal polypeptide and intestinal chloride secretion. In: Vasoactive intestinal polypeptide. Adv Peptide Hormone Res, vol 1. Raven Press, New York, pp 211–222Google Scholar
  94. Gaginella TS, Mascolo N, Izzo AA, Autore G, Capasso F (1994) Nitric oxide as a mediator of bisacodyl and phenophthalein laxative action: induction of nitric oxide synthase. J Pharmacol Exp Ther 270: 1239–1245PubMedGoogle Scholar
  95. Garcia-Villar R, Leng-Peschlow E, Ruckebusch Y (1980) Effect of anthraquinone derivatives on canine and rat intestinal motility. J Pharm Pharmacol 32: 323–329PubMedCrossRefGoogle Scholar
  96. Gattuso JM, Kamm MA (1994) Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 10: 47–65PubMedCrossRefGoogle Scholar
  97. Geboes K, Nijs G, Mengs U, Geboes KPJ, Van Damme A, de Witte P (1993) Effects of contact laxatives on intestinal and colonic epithelial cell proliferation. Pharmacology 47 (Suppl 1): 187–195PubMedCrossRefGoogle Scholar
  98. Ghadially FN, Parry EW (1966) An electro-microscope and histochemical study of melanosis coli. J Pharm Bact 92: 313–317CrossRefGoogle Scholar
  99. Gobel D (1978) Melanosis coli. Med Klin 73: 519–523Google Scholar
  100. Grindlay D, Reynolds T (1986) The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacology 16: 117–151CrossRefGoogle Scholar
  101. Gullikson GW, Bass P (1984) Mechanisms of action of laxative drugs. In: Csaky TZ (ed) Pharmacology of intestinal permeation II, vol 70. Springer-Verlag, Berlin Heidelberg New York, pp 419–459CrossRefGoogle Scholar
  102. Hattori M, Kim G, Motoike S, Kobashi K, Namba T (1982) Metabolism of sennosides by intestinal flora. Chem Pharm Bull (Tokyo) 30: 1338–1346CrossRefGoogle Scholar
  103. Hardcastle JD, Wilkins JL (1970) The action of sennosides and related compounds on human colon and rectum. Gut 11: 1038–1040PubMedCrossRefGoogle Scholar
  104. Harvey RE, Read AE (1973) Saline purgatives act by releasing cholecystokinin. Lancet 2: 185–187PubMedCrossRefGoogle Scholar
  105. Harvey RE, Read AE (1975) Mode of action of saline purgatives. Am Heart J 89: 810–812PubMedCrossRefGoogle Scholar
  106. Haubrich WS (1985) Constipation. In: Bockus J (ed) Gastroenterology. Saunders, Philadelphia, pp 111–124Google Scholar
  107. Haward LRC, Hughes-Roberts HE (1962) The treatment of constipation in mental hospitals. Gut 3: 85–90PubMedCrossRefGoogle Scholar
  108. Heaton KW (1972) Bile salts in health and disease. Churchill Livingstone, EdinburghGoogle Scholar
  109. Heiny BM (1976) Langzeitbehandlung mit einem pflanzlichen Laxativum. Serumelektrolyte und Säurenhaushalt. Arztliche Praxis 28: 563–564Google Scholar
  110. Hill MJ, Drasar BS, Williams REO, Meade TW, Cox AG, Simpson JEP, Morson BC (1975) Faecal bile-acids and Clostridia in patients with cancer of the large bowel. Lancet i: 535CrossRefGoogle Scholar
  111. Hietala P, Marvola M, Parviainen T, Lainonen H (1987) Laxative potency and acute toxicity of some anthraquinone derivatives, senna extracts and fractions of senna extracts. Pharmacol Toxicol 61:153–156PubMedCrossRefGoogle Scholar
  112. Hillestad B, Sund RB, Buajordet M (1982) Intestinal handling of bisacodyl and picosulphate by everted sacs of the rat jejunum and stripped colon. Acta Pharmacol Toxicol 51: 388–394CrossRefGoogle Scholar
  113. Hodgson J (1972) Effect of methylcellulose on rectal and colonic pressure in treatment of diverticular disease. Br Med J 3: 729–731PubMedCrossRefGoogle Scholar
  114. Hormann HP, Korting HC (1994) Evidence for the efficacy and safety of topical herbal drugs in dermatology: part 1: anti-inflammatory agents. Phytomedicine 1: 161–171CrossRefGoogle Scholar
  115. Husain A (1992) Economic aspects of exploitation of medicinal plants. In: Akerele O, Heywood V, Synge H (eds) Conservation of Medicinal Plants. University Press, Cambridge, pp 125–140Google Scholar
  116. Illingworth RS (1953) Abnormal substances excreted in human milk. Practitioner 171: 533–538PubMedGoogle Scholar
  117. Ishii Y, Tanizawa H, Takino Y (1990) Studies of Aloe III. Mechanism of cathartic effect. Chem Pharm Bull 38: 197–200PubMedCrossRefGoogle Scholar
  118. Itasaka S, Shirataori K, Takahashi T, Ishikawa M, Kanedo K, Suzuki Y (1992) Stimulation of intramural secretory reflex by luminal distension pressure in rat distal colon. Am J Physiol 263: G108–G114PubMedGoogle Scholar
  119. Izzo AA (1996) PAF and the digestive tract. A review. J Pharm Pharmacol 48: 1103–1111PubMedCrossRefGoogle Scholar
  120. Izzo AA, Mascolo N, Autore G, Di Carlo G, Capasso F (1993) Increased ex-vivo colonic generation of PAF induced by diphenylmethane stimulant laxatives in the rat, mice, guineapig and rabbits. J Pharm Pharmacol 45: 916–918PubMedCrossRefGoogle Scholar
  121. Izzo AA, Gaginella TS, Mascolo N Capasso F (1994) Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol 113: 228–232PubMedGoogle Scholar
  122. Izzo AA, Gaginella TS, Capasso F (1996a) The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnes Res 9: 133–138PubMedGoogle Scholar
  123. Izzo AA, Gaginella TS, Mascolo N, Borrelli F, Capasso F (1996b) NG-Nitro-L-arginine methyl ester reduces senna- and cascara-induced diarrhoea and fluid secretion in the rat. Eur J Pharmacol 301: 137–142PubMedCrossRefGoogle Scholar
  124. Izzo AA, Sautebin L, Rombola L, Capasso F (1997) The role of constitutive and inducible nitric oxide synthase in senna- and cascara-induced diarrhoea in the rat. Eur J Pharmacol 323: 93–97PubMedCrossRefGoogle Scholar
  125. Jones FA, Gotting EW (1972) Management of constipation. Blackwell and Mott, Oxford Kacere RD, Srivatsa SS, Tremaine WJ, Ebnet LE, Batts KP (1993) Chronic diarrhea due to surreptitious use of bisacodyl: case reports and methods for detection. Mayo Clin Proc 68: 355–357Google Scholar
  126. Kantor JL, Cooper LF (1937) The dietetic treatment of constipation with special reference to food fiber. Ann Intern Med 10: 965–978Google Scholar
  127. Kawai K, Mori H, Sugie S, Yoshimi N, Inoue T, Nakamura T, Nozawa Y, Matsushima T (1986) Genetoxicity in the hepatocyte/DNA repair test and toxicity to liver mitochondria of 1-hydroxyanthraquinone and several dihydroxyanthraquinones. Cell Biol Toxicol 4: 457–467CrossRefGoogle Scholar
  128. Kellogg JH (1921) The new dietetics. Modern Medicine Publishing, Battle CreekGoogle Scholar
  129. Kierman JA, Heinicke EH (1989) Sennosides do not kill myenteric neurons in the colon of the rat or mouse. Neuroscience 30: 837–842CrossRefGoogle Scholar
  130. Kinnunen O, Salokannel J (1987) Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk laxative. Ann Clin Res 19: 321–323PubMedGoogle Scholar
  131. Kinnunen O, Winblad I, Koistinen P, Salokannel J (1993) Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology 47 (Suppl 1): 253–255PubMedCrossRefGoogle Scholar
  132. Kleibeuker JH, Cats A, Zwart N, Mulder NH, Hardonk MJ, de Vries EGE (1995) Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides. J Natl Cancer Inst 87: 152–153Google Scholar
  133. Kluck P, ten Kate FJW, Schouten WR, Bartels KCM, Tibboel D, van der Kamp AWM, Molenaar JC, van Blankenstein M (1987) Efficacy of antibody NF2F11 staining in the investigation of severe long-standing constipation. Gastroenterology 93: 872–875PubMedGoogle Scholar
  134. Koskela E, Kulju T, Collan Y (1989) Prevalence, distribution and histologic feature in 200 consecutive autopsies at Kuopio University Central Hospital. Dis Colon Rectum 32: 235–239PubMedCrossRefGoogle Scholar
  135. Krishnamurthy S, Schuffler MD, Rohrmann CA, Pope CE (1985) Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 88: 26–34PubMedGoogle Scholar
  136. Kune GA (1993) Laxative use not a risk for colorectal cancer. Data from the Melbourne colorectal cancer study. Z Gastroenterol 31: 140–143PubMedGoogle Scholar
  137. Kune GA, Kune S, Field B, Watson LF (1988) The role of chronic constipation diarrhoea, and laxative use in the etiology of large bowel cancer. Data from the Melbourne colorectal cancer study. Dig Colon Rect 31: 507–512CrossRefGoogle Scholar
  138. Larven A, Sloane A, Munch J (1952) Biossay of cathartics. I. Emodine type. J Am Pharm Assoc 41: 548–552Google Scholar
  139. Lawson M, Kern F, Everson GT (1985) Gastrointestinal transit time in human pregnancy: proliferation by postpartum normalization. Gastroenterology 89: 996–999PubMedGoogle Scholar
  140. Lemaitre G, L’Herminé C, Decoulx M, Houlcke M, Linquette M (1969) Les lesions coliques par abus de laxatifs. Presse Med 77: 393–394PubMedGoogle Scholar
  141. Leng-Peschlow E (1980) Inhibition of intestinal water and electrolyte absorption by senna derivatives in rats. J Pharm Pharmacol 32: 330–335PubMedCrossRefGoogle Scholar
  142. Leng-Peschlow E (1986) Acceleration of large intestine transit time in rats by sennosides and related compounds. J Pharm Pharmacol 38: 369–373PubMedCrossRefGoogle Scholar
  143. Leng-Peschlow E (1992) Senna and its rational use. Pharmacology 44 (Suppl 1): 1–52Google Scholar
  144. Leng-Peschlow E, Mengs U (1995) Senna laxatives: safe and effective. Pharmaz Zeit 140: 668–674Google Scholar
  145. Leng-Peschlow E, Odenthal KP, Voderholzer W, Muller-Lissner S (1993) Chronic sennoside treatment does not cause habituation and secondary hyperaldosteronism in rats. Pharmacology 47 (Suppl 1): 162–171PubMedCrossRefGoogle Scholar
  146. Lesna M, Hamlyn AN, Venables CW, Record CD (1977) Chronic laxative abuse associated with pancreatic islet cell hyperplasia. Gut 18: 1032–1035PubMedCrossRefGoogle Scholar
  147. Levine D, Goode AW, Wingate DL (1981) Purgative abuse associated with reversible cachexia, hypogammaglobulinemia, and finger clubbing. Lancet 1: 919–920PubMedCrossRefGoogle Scholar
  148. Lium R, Florey HW (1939) The action of magnesium sulphate on the intestine of the cat. Quarterly J Exp Physiol 29: 303–319Google Scholar
  149. Longo R (1980) Attività e metabolismo nel topo di componenti la corteccia di Rhamnusfrangula e di prodotti sintetici a struttura antrachinonica. Boll Chim Farm 119: 669–684PubMedGoogle Scholar
  150. Lowy A (1960) Bowel reabilitation in the chronically constipated patient. Int Rec Med 173: 303–305PubMedGoogle Scholar
  151. Lyden-Sokolowski A, Nilsson A, Sjoberg P (1993) Two-year carcinogenicity study with sennosides in the rat: emphasis on gastrointestinal alterations. Pharmacology 47: 209–215PubMedCrossRefGoogle Scholar
  152. Maenz DD, Forsyth GW (1982) Ricinoleate and deoxycholate are calcium ionophore in jejunal brush borders. J Memb Biol 70: 125–133CrossRefGoogle Scholar
  153. Mahon R, Palmade J (1974) Traitement de la constipation chez la femme enceinte. Gaz Med Fr 81: 3259–3260Google Scholar
  154. Mascolo N, Autore G, Izzo AA, Biondi A, Capasso F (1992) Effects of senna and its active compounds rhein and rheinanthrone on PAF formation by rat colon. J Pharm Pharmacol 44: 693–695PubMedCrossRefGoogle Scholar
  155. Mascolo N, Gaginella TS, Izzo AA, Di Carlo G, Capasso F (1994a) Nitric oxide involvement in sodium choleate-induced fluid secretion and diarrhoea in rats. Eur J Pharmacol 264: 21–26PubMedCrossRefGoogle Scholar
  156. Mascolo N, Izzo AA, Autore G, Barbato F, Capasso F (1994b) Nitric oxide and castor oil-induced diarrhea. J Pharmacol Exp Ther 268: 291–295PubMedGoogle Scholar
  157. Mascolo N, Izzo AA, Barbato F, Capasso F (1993) Inhibitors of nitric oxide synthase prevent castor oil-induced diarrhoea in rats. Br J Pharmacol 108: 861–864PubMedGoogle Scholar
  158. Mascolo N, Izzo AA, Gaginella TS, Capasso F (1996) Relationship between nitric oxide and platelet activating factor in castor oil-induced mucosal injury in the rat duodenum. Naunyn Schmiedebergs Arch Pharmacol 353: 680–684PubMedCrossRefGoogle Scholar
  159. Mascolo N, Meli R, Autore G, Capasso F (1988a) Senna still causes laxation in rats maintained on a diet deficient in essential fatty acids. J Pharm Pharmacol 40: 882–884PubMedCrossRefGoogle Scholar
  160. Mascolo N, Meli R, Autore G, Capasso F (1988b) Evidence against a dependence of the senna effect on prostaglandin formation. Pharmacology 36 (Suppl 1): 92–97PubMedCrossRefGoogle Scholar
  161. McCance RA, Widdowson WM (1955) Old thoughts and new work on bread white and brown. Lancet 2: 205–210CrossRefGoogle Scholar
  162. Mc Clure Browne JC, Edmunds V, Fairbairn IW, Reid DD (1957) Clinical and laboratory assessments of senna preparation. Br Med J 1: 436–439CrossRefGoogle Scholar
  163. McConnell AA, Eastwood MA, Mitchell WD (1974) Physical characteristics of vegetable foodstuffs that could influence bowel function. J Sci Food Agric 25: 1457–1464PubMedCrossRefGoogle Scholar
  164. Mc Naughton WK, Gall DG (1991) Mechanisms of platelet activating factor-induced electrolyte transport in the rat jejunum. Eur J Pharmacol 200: 17–23CrossRefGoogle Scholar
  165. Meisel JL, Bergman D, Graney D, Saunders DR, Rubin LE (1977) Human rectal mucosa: proctoscopic and morphological changes caused by laxatives. Gastroenterology 72: 1274–1279PubMedGoogle Scholar
  166. Mereto E, Ghia M, Brambilla G (1996) Evaluation of the potential carcinogenic activity of senna and cascara glycosides for the rat colon. Cancer Lett 101: 79–83PubMedCrossRefGoogle Scholar
  167. Milner P, Belai A, Tomlinson A, Hoyle CV, Sarner S, Burnstock G (1992) Effect of long-term laxative treatment on neuropeptides in rat mesenteric vessels and caecum. J Pharm Pharmacol 44: 777–779PubMedCrossRefGoogle Scholar
  168. Moreto M, Gonalons E, Mylonakis N, Giraldes A, Torralba A (1979) 3,3-bis-(4-hydroxyphenyl)-7-methyl-2-indolinone (BHMI), the active metabolite of the laxative sulisatin. Arzneimittelforschung 29: 1561–1564PubMedGoogle Scholar
  169. Moriarty KJ, Dawson AM (1984) Use and abuse of cathartics. In: Csaky TZ (ed) Pharmacology of intestinal permeation II. vol 70. Springer-Verlag, Berlin Heidelberg New York, pp 509–531CrossRefGoogle Scholar
  170. Moriarty KJ, Silk D (1988) Laxative abuse. Dig Dis Sci 6: 15–29CrossRefGoogle Scholar
  171. Mori H, Sugie S, Niwa K, Takahashi M, Kawai K (1985) Induction of intestinal tumors in rat by chrysazin. Br J Cancer 52: 781–783PubMedCrossRefGoogle Scholar
  172. Mori H, Sugie S, Niwa K, Yoshimi N, Tanaka T, Hirono I (1986) Carcinogenicity of chrysazin in large intestine and liver of mice. Jpn J Cancer Res 77: 871–876PubMedGoogle Scholar
  173. Mori H, Yoshimi N, Iwata H, Mori Y, Hara A, Tanaka T, Kawai K (1990) Carcinogenicity in rats: induction of large bowel liver and stomach neoplasms. Carcinogenesis 11: 799–802PubMedCrossRefGoogle Scholar
  174. Muller SO, Eckert I, Lutz WK, Stopper H (1996) Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated? Mutat Res Genet Toxicol 371: 165–173Google Scholar
  175. Muller-Lissner SA (1993) Adverse effects of laxatives: fact and fiction. Pharmacology 47: 138–145PubMedCrossRefGoogle Scholar
  176. Muller-Lissner SA (1993) Laxative-induced damage to the colon. In: Guslandi M, Braga PC (eds) Drug-induced injury to the digestive system. Springer-Verlag, Berlin Heidelberg New York, pp 131–142CrossRefGoogle Scholar
  177. Munch JC, Calesnick B (1960) Laxative studies. Human threshold doses of white and yellow Phenolphthalein. Clin Pharmacol Ther 1: 311–315PubMedGoogle Scholar
  178. Nakamura GJ, Schneiderman LJ, Klauber MR (1984) Colorectal cancer and bowel habits. Cancer 54: 1475–1477PubMedCrossRefGoogle Scholar
  179. Nell G, Rummell W (1984) Action mechanisms of secretagogue drugs. In: Csaky TZ (ed) Pharmacology of intestinal permeation II, vol 70. Springer-Verlag, Berlin Heidelberg New York, pp 461–508CrossRefGoogle Scholar
  180. Newal CA, Anderson LA, Phillipson JD (1996) Herbal Medicines. The Pharmaceutical Press, LondonGoogle Scholar
  181. Nijs G, de Witte P, Lemli J (1991) Role of prostaglandin E2 in the secretion caused by rheinanthrone and rhein anthraquinone in the small intestine. Gastroenterology 100: A698Google Scholar
  182. Nishioka I (1985) Discovery of new biological activities and the active components in rhubarb. In: Takemi T, Hasegava M, Kumagai A, Otsuga Y (eds) Herbal Medicine: kampo, past and present. Tsumura Juntendo Inc, Tokio, pp 41–51Google Scholar
  183. Nusko G, Schneider B, Muller G, Kusche J, Hahn EG (1993) Retrospective study on laxative use and melanosis coli as risk factors for colorectal neoplasma. Pharmacology 47 (Suppl 1): 234–241PubMedCrossRefGoogle Scholar
  184. Odenthal K, Ziegler D (1988) In vitro effects of anthraquinones on rat intestine and uterus. Pharmacology 36 (Suppl 1): 57–65PubMedCrossRefGoogle Scholar
  185. Ornstain MH, McLain Baird I (1987) Dietary fiber and the colon. Mol Aspects Med 9: 41–67CrossRefGoogle Scholar
  186. Osten JR, Naterson BJ, Rogers AJ (1980) Laxative abuse syndrome. Am J Gastroenterol 74: 451–458Google Scholar
  187. Painter NS, Almeida AZ, Colebourne KW (1972) Unprocessed bran in treatment of diverticular disease of the colon. Br Med J 1: 137–140CrossRefGoogle Scholar
  188. Parry E, Shields R, Turnbull AC (1970) Transit time in the small intestine in pregnancy. J Obstet Gynaecol Br Commow 77: 900–901CrossRefGoogle Scholar
  189. Parsons DS (1968) Methods for the investigations of intestinal absorption. In: Code CF (ed) Handbook of physiology, alimentary canal, vol III. American Physiological Society, pp 1177–1216Google Scholar
  190. Passmore AP, Wilson-Davies K, Stoker C, Scott ME (1993) Chronic constipation in long stay elderly patients: a comparison of lactulose and senna-fiber combination. Br Med J 307: 769–771CrossRefGoogle Scholar
  191. Phillips SF, Gaginella TS (1977) Intestinal secretion as a mechanism in diarrheal disease. In: Jerzy-Glass GB (ed) Progress in gastroenterology, vol III. Grune and Stratton, New York, pp 481–504Google Scholar
  192. Pinto A, Calignano A, Mascolo N, Autore G, Capasso F (1989) Castor oil increases intestinal formation of platelet activating factor and acid phosphatase release in the rat. Br J Pharmacol 96: 872–874PubMedGoogle Scholar
  193. Powell DW (1983) Neurohumoral control of intestinal secretion. In: Turnberg LA (ed) Intestinal secretion. Knapp Drewett and Sons, Great Britain, pp 42–45Google Scholar
  194. Prochnow L(1911) Experimentelle Beiträge zur Kenntnis der Wirkung von Volksabortiva. Arch Int Pharmacodyn 21: 313–319Google Scholar
  195. Racagni G, Cantaluppi S, Fumagalli R (1986) Farmacologia generale ed applicata. Masson, Milano, p 749Google Scholar
  196. Rachmilewitz D, Karmeli F, Okon E (1980) Effects of bisacodyl on cAMP and prostaglandin E2 contents, Na-K-ATPase, adenylylcyclase, and phosphodiesterase of rat intestine. Dig Dis Sci 25: 602–608PubMedCrossRefGoogle Scholar
  197. Rask-Madsen J, Bukhave K (1981) The role of prostaglandins in diarrhoea. Clin Res Rev 1 (Suppl 1): 33–48Google Scholar
  198. Rask-Madsen J, Bukhave K (1983) Prostaglandins and intestinal secretion. In: Turnberg LA (ed) Intestinal secretion, Knapp Drewett and Sons, Oxford, pp 76–83Google Scholar
  199. Rawson MD (1966) Cathartic colon. Lancet 1: 1121–1124PubMedCrossRefGoogle Scholar
  200. Refit (1996) Repertorio fitoterapico. OEMF, MilanoGoogle Scholar
  201. Riemann JF, Schenk J, Ehler R, Schmidt H, Koch H (1978) Ultrastructural changes of colonic mucosa in patients with chronic laxative misuse. Acta Hepato-Gastroenterol 25: 213–218Google Scholar
  202. Riemann J, Schmidt H, Zimmerman W (1980) The fine structure of colonic submucosal nerves in patients with chronic laxative abuse. Scand J Gastroenterol 15: 761–768PubMedCrossRefGoogle Scholar
  203. Robbers JE, Speedie MK, Tyler VE (1996) Pharmacognosy and pharmacobiotechnology. Williams and Wilkins, Baltimore, p 51Google Scholar
  204. Roggin GH, Banwell JG, Yardley JH, Hendrix TH (1972) Unimpaired response of rabbit jejunum to cholera toxin after selective damage in villus epithelium. Gastroenterology 63: 981PubMedGoogle Scholar
  205. Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, Bedogni G, Paris B, Svanoni F, Girola M (1993) Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dig Colon Rectum 3: 227–234CrossRefGoogle Scholar
  206. Rondanelli R, Autelli F, Guaglio R (1980) Valutazione delle interazioni nelle associazioni tra farmaci. Bertolli A, Mascherpa P, Storti E (eds). ESAM, RomaGoogle Scholar
  207. Rosprich G (1980) Dauerbehandlung mit Laxantien. Therapiewoche 30: 5836–5837Google Scholar
  208. Rudolph RL, Mengs U (1988) Electron microscopical studies on rat intestine after long-term treatment with sennosides. Pharmacology 36 (Suppl 1): 188–193PubMedCrossRefGoogle Scholar
  209. Sarna K, Otterson M (1988) Gastrointestinal motility: some basic concepts. Pharmacology 36 (Suppl 1): 7–14PubMedCrossRefGoogle Scholar
  210. Sarner M (1976) Problems caused by laxatives. Practic 216: 661–664Google Scholar
  211. Saunders DR, Sillery J, Rachmilewitz D (1975) Effect of dioctyl sodium sulpho-succinate on structure and function of rodent and human intestine. Gastroenterology 69: 380–386PubMedGoogle Scholar
  212. Saunders DR, Sillery J, Rachmilewitz D, Rubin CE, Tytgat GN (1977) Effect of bisacodyl on the structure and function of rodent and human intestine. Gastroenterology 72: 849–856PubMedGoogle Scholar
  213. Saunders DR, Sillery J, Surawica C, Tytgat GN (1978) Effect of Phenolphthalein on the function and structure of iodent and human intestine. Dig Dis Sci 23: 909–913CrossRefGoogle Scholar
  214. Schmidt A, Von Noorden C (1936) Klinik der Darmkrankheiten, 2nd edn. Bergmann, Munich, p 382Google Scholar
  215. Schultz SG, Zalusky R (1964) Ion transport in isolated rabbit ileum. I. Short-circuit current and Na+ fluxes. J Gen Physiol 47: 567–584Google Scholar
  216. Schwartz WB, Relman AS (1953) Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J Clin Invest 32: 258–271PubMedCrossRefGoogle Scholar
  217. Scott RS (1965) Management of constipation in obstetrics: A clinical report on 592 cases. West Med 6: 342–344Google Scholar
  218. Shelton MG (1980) Standardized senna in the management of constipation in the Puerperium. S Afr Med J 57: 78–80PubMedGoogle Scholar
  219. Siegers CP (1992) Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 13: 229–231PubMedCrossRefGoogle Scholar
  220. Siegers CP, von Hertzberg Lottin E, Otte M, Scheider B (1993) Anthranoid laxative abuse — a risk for colorectal cancer? Gut 34: 1099–1101PubMedCrossRefGoogle Scholar
  221. Smith B (1968) Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut 9: 139–143PubMedCrossRefGoogle Scholar
  222. Smith B (1973) Pathologic changes in the colon produced by anthraquinone purgatives. Dis Colon Rectum 16: 455–458PubMedCrossRefGoogle Scholar
  223. Smith CW, Evans PR (1961) Bowel motility. A problem in institutionalized geriatric care. Geriatrics 16: 189–192Google Scholar
  224. Sonnenberg A, Muller AD (1993) Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 47 (Suppl 1): 224–233PubMedCrossRefGoogle Scholar
  225. Speare GS (1951) Melanosis coli. Experimental observation on its production and elimination in twenty-three cases. Am J Surg 82: 631–637PubMedCrossRefGoogle Scholar
  226. Spiessens C (1991) Morphological and functional changes induced by laxatives in the intestinal mucosa. Thesis, Katholicke Universiteit, Leuven, p 145Google Scholar
  227. Spiessens C, de Witte P, Geboes K, Lemli J (1991) Experimental induction of pseudomelanosis coli by anthranoid laxatives and non-anthranoid laxatives. Pharmaceut Pharmacol Lett 1: 3–6Google Scholar
  228. Staumont G, Fioramonti J, Frexinas J, Bueno L (1988) Changes in colonic motility induced by sennosides in dogs: evidence of a prostaglandin mediation. Gut 29: 1180–1187PubMedCrossRefGoogle Scholar
  229. Steer HW, Colin-Jones DG (1975) Melanosis coli: studies on the toxic effects of irritant purgatives. J Pathol 115: 199–205PubMedCrossRefGoogle Scholar
  230. Stewart JJ, Gaginella TS, Bass P (1975a) Action of ricinoleic acid and structurally related fatty acids on the gastrointestinal tract. Effects on smooth muscle contractility in vitro. J Pharmacol Exp Ther 195: 347–354PubMedGoogle Scholar
  231. Stewart JJ, Gaginella TS, Olsen WA, Bass P (1975b) Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract. J Pharmacol Exp Ther 192: 458–467PubMedGoogle Scholar
  232. Sund RB, Lauterbach F (1986) Drug metabolism and metabolite transport in the small and large intestine: experiments with 1-naphthol and Phenolphthalein by luminal and contraluminal administration in the isolated guinea pig mucosa. Acta Pharmacol Toxicol 58: 74–83CrossRefGoogle Scholar
  233. Sund RB, Lauterbach F (1987) 1-Naphthol metabolism and metabolite transport in the small and large intestine. Effects of sulphate and phosphate ion omission, and of 2,6-dichloro-4-nitrophenol in the isolated guinea pig mucosa. Pharmacol Toxicol 60: 262–268Google Scholar
  234. Sund RB (1989) Pharmacokinetics of diphenolic laxatives. A status report. In: Koster AS, Richter E, Lauterbach F, Hartmann F (eds) Progress in pharmacology and clinical pharmacology, vol 7/2. Gustav Fischer Verlag, Stuttgart, pp 300–310Google Scholar
  235. Tamai H, Gaginella TS (1993) Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Radic Res Comm 19: 229–239CrossRefGoogle Scholar
  236. Thompson GW (1979) The irritable gut, functional disorders of the alimentary canal. University Park Press, Baltimore, p 275Google Scholar
  237. Thompson WG (1980) Laxatives: Clinical pharmacology and rational use. Drugs 19: 49–58PubMedCrossRefGoogle Scholar
  238. Tidmarsh CJ (1936) Chronic indigestion. Longman’s Green, Toronto, p 143Google Scholar
  239. Tikkanen L, Matsushima T, Natoris S (1983) Mutagenicity of anthraquinones in the salmonella pre-incubation test. Mutat Res 116: 297–304PubMedCrossRefGoogle Scholar
  240. Tonini M, Costa M (1990) A pharmacological analysis of the neuronal circuitry involved in distension-evoked enteric excitatory reflex. Neuroscience 38: 787–795PubMedCrossRefGoogle Scholar
  241. Toyoda K, Nishikawa A, Furukawa F, Kawanishi T, Hayashi Y, Takahashi M (1994) Cell proliferation induced by laxatives and related compounds in the rat intestine. Cancer Lett 83: 43–49PubMedCrossRefGoogle Scholar
  242. Travell J (1954) Pharmacology of stimulant laxatives. Ann NY Acad Sci 58: 416–425CrossRefGoogle Scholar
  243. Turnberg LA, Bieberdort FA, Morawski SG, Fordtran JS (1970) Interrelationship of chloride bicarbonate, sodium and hydrogen transport in the lumen ileum. J Clin Invest 49: 557–561PubMedCrossRefGoogle Scholar
  244. Tyler VE, Brady LR, Robbers JE (1988) Pharmacognosy, 9th edn. Lea and Febinger, Philadelphia, pp 60–62Google Scholar
  245. Tyler VE (1994) Herbs of choice. The therapeutic use of phytomedicinals. Pharmaceut Products Press, New York, pp 39–71Google Scholar
  246. Tytgat GNJ, Mathus-Vliegen L (1983) Laxatives-laxative abuse-cathartic colon. J Drug Res 8: 1844–1850Google Scholar
  247. Tzavella K, Schenkirsch S, Riepl RL, Odenthal KP, Leng-Peschlow (1995) Effect of long-term treatment with anthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon. Eur J Gastroenterol Hepatol 7: 13–20PubMedGoogle Scholar
  248. Ussing HH, Zehran K (1951) Active transport of sodium as the source of electric current in the short-circuit isolated from skin. Acta Physiol Scand 23: 110–127PubMedCrossRefGoogle Scholar
  249. Vago O (1969) Toxische und kaustische Komplikationen durch Gebrauch sogenannter fruchtabtreibender Arzneimittel. Z Geburtshilfe Gynakol 170: 272–277PubMedGoogle Scholar
  250. Verhaeren E (1980) Mitochondrial uncoupling activity as a possible base for a laxative and antipsoriatic effect. Pharmacology 20 (Suppl 1): 43–49PubMedCrossRefGoogle Scholar
  251. Wager HP, Melosh WD (1958) The management of constipation in pregnancy. Q Rev Surg 15: 30–34PubMedGoogle Scholar
  252. Wald A, van Thield DH, Hoechstaller L, Gavaler JS, Egler KM, Varm R, Scott L, Lester R (1982) Effect of pregnancy on gastrointestinal tract. Dig Dis Sci 27: 1015–1018PubMedCrossRefGoogle Scholar
  253. Wallace JL, Whittle BJR (1986) Profile of gastrointestinal damage induced by platelet-activating factor. Prostaglandins 32: 127–141CrossRefGoogle Scholar
  254. Wanitschke R (1980) Influence of rhein on electrolyte and water transfer in the isolated rat colonic mucosa. Pharmacology 20 (Suppl 1): 21–26PubMedCrossRefGoogle Scholar
  255. Wanitschke R (1987) Konsequenzen des Laxanzienabusus. Int Welt 5: 113–118Google Scholar
  256. Weisbroadt NW (1987) Motility of the small intestine. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven Press, New York, pp 631–664Google Scholar
  257. Werthmann MW, Krees SV (1973) Quantitative excretion of senokot in human breast milk. Med Ann Distr Columbia 42: 4–5Google Scholar
  258. Westendorf J, Marquardt H, Poginsky B, Dominiak M, Shmidt J, Marquard H (1990) Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res 340: 1–12Google Scholar
  259. Wichtl M (1984) Teedrogen. Wisswnschaftliche Verlag-Gesellschaft, Stuttgart, pp 311–314Google Scholar
  260. Wittoesch JH, Jackman RJ, Mc Donald JR (1958) Melanosis coli. General review and a study of 887 cases. Dis Colon Rectum 1: 172–180PubMedCrossRefGoogle Scholar
  261. Yagi T, Miyawaki Y, Nishikawa T, Yamauchi K, Kuwano S (1988) Involvement of prostaglandin E-like material in the purgative action of rheinanthrone, the intraluminal active metabolite of sennosides A and B in mice. J Pharm Pharmacol 40: 27–30PubMedCrossRefGoogle Scholar
  262. Yang K, Fan K, Mengs U, Lipkin M (1993) Effects of sennosides and non-anthranoid laxatives on cytochemistry of epithelial cells in rat colon. Pharmacology 47 (Suppl 1): 196–204PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1997

Authors and Affiliations

  • Francesco Capasso
    • 1
  • Timothy S. Gaginella
    • 2
  1. 1.Department of Experimental PharmacologyUniversity of Naples “Federico II”NaplesItaly
  2. 2.School of PharmacyUniversity of WisconsinMadisonUSA

Personalised recommendations